Health Affairs, 25, no. 4 (2006): w272-w275 (Published online 6 June 2006) doi: 10.1377/hlthaff.25.w272 © 2006 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Cost To Cover Uninsured   Let Health IT Market Evolve   How Rate Health IT Progress?   HIV/AIDS In India, China

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gibson, M. Articles by Santa, J. Search for Related Content PubMed PubMed Citation Articles by Gibson, M. Articles by Santa, J. Related Collections Access To Care Consumer Issues Evidence-Based Medicine Health Reform Insurance Coverage Managed Care - Medicaid Medicaid Pharmaceuticals State/Local Issues

Web Exclusives

PERSPECTIVE

The Drug Effectiveness Review Project: An Important Step Forward

Peter Neumann’s paper on the Drug Effectiveness Review Project (DERP) is a constructive if incomplete point of departure for discussing the work done by the project and the use of that work by decisionmakers in states and elsewhere. This Perspective attempts to establish the proper context for judging the DERP by comparing its product and processes with those commonly produced and used by industry and other parties. It also provides a direct response to the criticisms of the project noted by Neumann.

                      What's this?